Literature DB >> 8423396

Sunlight and skin-associated lymphoid tissues (SALT): if UVB is the trigger and TNF alpha is its mediator, what is the message?

J W Streilein1.   

Abstract

The damaging effects on cutaneous immunity of low-dose ultraviolet B (UVB) radiation in sunlight are genetically determined in mice. Polymorphic alleles at the Tnf alpha and Lps loci dictate whether mice are UVB susceptible or resistant, i.e., develop contact hypersensitivity or not when hapten is painted on UVB-exposed skin. In mice, UVB susceptibility is mediated almost exclusively by tumor necrosis factor-alpha (TNF alpha). Circumstantial evidence implicates urocanic acid (UCA) in the stratum corneum as the photoreceptor for UVB, and recent results suggest that cis-UCA in turn instigates the intraepidermal accumulation of TNF alpha. It is hypothesized that TNF alpha interrupts the induction of contact hypersensitivity by preventing epidermal Langerhans cells from carrying hapten to the draining lymph node, where activation of naive, hapten-specific T cells must first occur. The phenotypic traits of UVB susceptibility (UVB-S) and UVB resistance (UVB-R) have now been documented in human beings, and the frequency of UVB-S is high (approximately 40-45%) in both Caucasians and individuals with deeply pigmented skin. Because the frequency of UVB-S is extremely high in patients with biopsy-proved basal and squamous cell skin cancer, this trait appears to be a risk factor for this disease. The unexpectedly high frequency of UVB-S in human beings, including black-skinned persons, implies that the trait is not perceived by evolutionary processes as deleterious. The possible selective advantages conferred by alleles that determine UVB-S are discussed with respect to cutaneous infections in which mortality and morbidity are primarily mediated by immunopathogenic processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423396     DOI: 10.1111/1523-1747.ep12355578

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  Basal cell carcinoma.

Authors:  J T Lear; I Harvey; D de Berker; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

Review 2.  The role of dendritic cells in cutaneous immunity.

Authors:  M B Lappin; I Kimber; M Norval
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

3.  Urocanic acid suppresses the activation of human neutrophils in vitro.

Authors:  K Kivistö; K Punnonen; J Toppari; L Leino
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

4.  Lack of metallothionein-I and -II exacerbates the immunosuppressive effect of ultraviolet B radiation and cis-urocanic acid in mice.

Authors:  V E Reeve; N Nishimura; M Bosnic; A E Michalska; K H Choo
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

5.  Studies on delayed systemic effects of ultraviolet B radiation on the induction of contact hypersensitivity, 3. Dendritic cells from secondary lymphoid organs are deficient in interleukin-12 production and capacity to promote activation and differentiation of T helper type 1 cells.

Authors:  T Kitazawa; J W Streilein
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

6.  Fluorescent light activates the immunomodulator cis-urocanic acid in vitro: implications for patients with systemic lupus erythematosus.

Authors:  H McGrath; J M Bell; J W Haycock
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

7.  Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.

Authors:  I Kurimoto; S F Grammer; T Shimizu; T Nakamura; J W Streilein
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Evidence that ultraviolet B radiation induces tolerance and impairs induction of contact hypersensitivity by different mechanisms.

Authors:  T Shimizu; J W Streilein
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

Review 9.  Photoimmunology.

Authors:  Craig A Elmets; Cather M Cala; Hui Xu
Journal:  Dermatol Clin       Date:  2014-05-05       Impact factor: 3.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.